IRIS
ASCARI, EDOARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.919
EU - Europa 2.593
AS - Asia 1.836
SA - Sud America 76
OC - Oceania 12
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.448
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.897
CN - Cina 1.503
IE - Irlanda 683
UA - Ucraina 464
FI - Finlandia 323
RU - Federazione Russa 283
SE - Svezia 268
DE - Germania 267
SG - Singapore 238
GB - Regno Unito 108
IT - Italia 98
BR - Brasile 67
FR - Francia 43
HK - Hong Kong 23
CA - Canada 19
IN - India 19
BE - Belgio 17
NL - Olanda 16
IR - Iran 15
AU - Australia 11
AT - Austria 5
BD - Bangladesh 4
DK - Danimarca 4
EU - Europa 4
IQ - Iraq 4
AR - Argentina 3
EC - Ecuador 3
GR - Grecia 3
JP - Giappone 3
RO - Romania 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IL - Israele 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
MU - Mauritius 2
PK - Pakistan 2
TR - Turchia 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
EG - Egitto 1
ES - Italia 1
GE - Georgia 1
GT - Guatemala 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
SA - Arabia Saudita 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 7.448
Salva come PNG Salva come JPEG
Città #
Dublin 682
Chandler 591
Jacksonville 570
Nanjing 452
Boardman 202
Nanchang 191
Ashburn 167
Princeton 137
Beijing 125
Hebei 125
Lawrence 125
Shenyang 124
Medford 121
Changsha 113
Wilmington 112
Jiaxing 99
Singapore 88
Helsinki 86
Ann Arbor 77
Hangzhou 70
Tianjin 70
Moscow 57
Milan 38
Shanghai 38
Woodbridge 33
Norwalk 28
Verona 24
Hong Kong 20
New York 20
Fairfield 19
Brussels 17
Los Angeles 17
Toronto 17
Seattle 15
Houston 12
Kunming 12
Jinan 10
Auburn Hills 9
Des Moines 9
Falkenstein 9
Ningbo 8
Piscataway 8
San Genesio Ed Uniti 8
Taizhou 7
Falls Church 6
Guangzhou 6
Orange 6
Zhengzhou 6
Andover 5
Ardabil 5
Chicago 5
Fuzhou 5
Melbourne 5
São Paulo 5
Belo Horizonte 4
Brasília 4
Lanzhou 4
San Francisco 4
Munich 3
Phoenix 3
Pune 3
Rio de Janeiro 3
Rockville 3
Rome 3
Sacramento 3
Tappahannock 3
Tuglie 3
Washington 3
Arlington 2
Barueri 2
Borås 2
Brno 2
Changchun 2
Colombo 2
Dearborn 2
Delhi 2
Frankfurt am Main 2
Leawood 2
Naples 2
New Delhi 2
Newark 2
Norwich 2
Pavia 2
Romainville 2
Santa Clara 2
Sorocaba 2
Sydney 2
Tashkent 2
Tel Aviv 2
The Dalles 2
Tokyo 2
Vienna 2
'Asir Region 1
Adelaide 1
Almaty 1
Amman 1
Amsterdam 1
Assis 1
Athens 1
Bacoli 1
Totale 4.918
Salva come PNG Salva come JPEG
Nome #
5' Nucleotidase in chronic B cell leukemias: a cytochemical and ultrastructural study 92
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 89
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 87
Anomalous erythrocytes produced by rabbits with liver damage. 86
Acute promyelocitic leukemia toluidine blue subtype. 85
AMYLOIDOSIS AL 84
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 84
A further case of myeloproliferative syndrome with reciprocal translocation (8;13)(p11;q12) 84
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 83
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 83
Acute phase proteins and prognosis in multiple myeloma. 83
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 80
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 80
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 79
The clinical value of tumor burden at diagnosis in Hodgkin lymphoma 79
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 79
Ageing of rabbit red cells in vitro: membrane modifications and their possible role in red cell survival in vivo. 77
Severe platelet disfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa 76
Anemie megaloblastiche. 76
Response to cyclosporin A and rhG-CSF in a case of aplastic anemia. 76
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 75
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 74
Reactive hemophagocytosis in Ki-1 positive largeb cell lymphoma: a case study. 73
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 72
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 72
Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia 71
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 71
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 69
An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression. 69
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 68
Changing clinical presentation of multiple myeloma. 68
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 68
Possible evolution of human parvovirus B19 infection into erythroleukemia 67
Biologia e clinica del mieloma multiplo. 67
On the usefulness of PAS reaction for the prognosis of acute lymphoblastic leukemia. 67
IMMUNOENZYMATIC DETECTION OF PROTEINS TRANSFERRED ON NITROCELLULOSE AFTER FIXATION AND STAINING IN POLYACRYLAMIDE GEL 66
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 66
Acquired immune thrombastenia: a new bleeding disorder. 66
Glycopeptides of erythrocyte membranes in some hematological disorders 66
RELEVANCE OF CLASS, MOLECULAR WEIGHT AND ISOELECTRIC POINT IN PREDICTING HUMAN LIGHT CHAIN AMYLOIDOGENICITY. 65
STUDY OF THREE PATIENTS WITH MONOCLONAL GAMMAPATHIES AND "LUPUS-LIKE" ANTICOAGULANTS. 65
International prognostic scoring system and other prognostic systems for myelodysplastic syndromes. 64
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 64
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 64
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 62
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 62
Behaviour of young and old desialylated rabbit erythrocytes in vivo. 62
Morphological features and prognostic implication in a retrospective analysis of 370 patients with myelodysplastic syndrome 62
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 62
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 62
CHARACTERIZATION OF ANTI-STREPTOLYSIN O ACTIVITY OF A HUMAN MONOCLONAL IgG LAMDA. 62
Applicazioni cliniche dei fattori di crescita emopoietici. 61
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 61
[Biochemical modifications of the erythrocyte membrane in various red cell disorders] 60
Significance of marrow-blood barrier for CFU-GM in patients with acute nonlymphoid leukemia (AnLL) 60
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 59
Silymarine during maintenance therapy of acute promyelocytic leukemia. 59
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 59
Structural modifications in membrane glycoproteins during the erythrocyte life-span. 58
Applicazioni cliniche della citometria. 58
Fisiopatologia dell'eritrocito. 58
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis 58
Acute non-lymphoblastic leukemia. Correlation between clinical and hematological parameters in 87 adult patients. 58
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis 58
[Pure acute monocytic leukaemia: morphological, cytochemical and clinical study of 14 cases (author's transl)]. 58
Membrane CD22 defines circulating myeloma-related cells as mature or later B cells 58
Chemotherapy-induced leukonychia 58
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 57
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 57
Acute promyelocytic leukemia: morphological and clinical features. 56
[Glycoproteins of the erythrocyte membrane in normal and pathological conditions] 56
The syndrome of abnormal chromatin clumping in leucocytes: clinical and biological study of a case. 56
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 55
Terapia del mieloma multiplo. 55
Membrane sialic acid and behaviour in vivo of rabbit "stress" macroreticulocytes. 55
A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma. 55
Idarubicin and cytosine arabinoside in the induction and maintenance therapy of high risk myelodysplastic syndromes 54
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 54
Erythrocyte membrane modifications in chronic granulocytic leukaemia 53
In vivo behaviour of neuraminidase-treated rabbit erythrocytes and reticulocytes 53
Flow cytometric analysis of paraffin embedded material in human gastric cancer. 53
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 53
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. 53
IL MIELOMA MULTIPLO 52
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons] 52
New approaches to cancer chemotherapy. 51
Tetrahydrofolate dehydrogenase cytochemistry in acute lymphoblastic leukemia. 51
Cytokinetic studies on circulating neoplastic cells of Hodgkin's disease. 51
Oral idarubicin and prednisone for advanced, previously untreated multiple myeloma: a pilot study. 51
Osteonecrosi avascolare del massiccio facciale in corso di terapia con bisfosfonati [Avascular jaw osteonecrosis associated with bisphophonate therapy]. 51
Lymphocyte reactivity in chronic lymphocytic leukaemia: effect of repeated and prolonged stimulation with PHA and PWM. 51
Il trattamento del carcinoma mammario. 50
[Prophylaxis and therapy of neuro-meningeal involvement of acute lymphoblastic leukemia. Case reports and critical review of literature (author's transl)] 50
Clinical relevance of two in vitro tests based on CFU-GM assay in the study of granulopoietic failure 50
Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura 50
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP 50
Thalidomide treatment reduces apoptosis levels in bone marrow cells from patients with myelodysplastic syndromes 50
Multilineage dysplasia without increased blasts identifies a poor prognosis subset of myelodysplastic syndromes. 49
Establishment and characterization of a B-cell line derived from a patient with a myelodysplastic syndrome which expresses myelomonocytic and lymphoid markers. 49
Post remission chemotherapy in adult non lymphoblastic leukemia: results of two protocols including intensive or non-intensive consolidation therapy. 49
Totale 6.386
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.694
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.694
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020223 0 0 0 0 0 0 0 0 0 159 64 0
2020/2021875 92 71 32 84 7 129 3 134 32 137 117 37
2021/2022650 9 1 21 10 24 35 12 35 23 32 88 360
2022/20231.811 217 129 21 136 183 174 0 85 777 9 54 26
2023/2024550 80 92 25 59 51 133 15 32 7 14 25 17
2024/2025921 44 142 37 52 25 49 53 109 391 19 0 0
Totale 7.522